08/06/2024
4:21 PM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
4:20 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
4:21 PM | Anavex Life Sciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/21/2024
3:30 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
6:30 AM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:01 AM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
7:00 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
5:01 AM | Anavex Life Sciences (Filer)
| Form DEF 14A | |
05/06/2024
5:03 AM | Anavex Life Sciences (Filer)
| Form DEFA14A | |
04/01/2024
5:00 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
7:34 AM | Anavex Life Sciences (Subject)
MISSLING CHRISTOPHER U (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
5:03 AM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
5:03 AM | Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
5:04 AM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
5:04 AM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
5:05 AM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:01 PM | Anavex Life Sciences (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/22/2024
10:34 AM | Anavex Life Sciences (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/12/2024
7:00 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
7:00 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
3:30 PM | Anavex Life Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
